Minimize complications, maximize success

Article

When considering PRK and LASIK, a standard pre- and post-procedure drug therapy regimen is important to minimize complications of the procedures.

"LASIK and PRK are more successful than ever. But no matter how technologically advanced we get, we still need proper optometric management from a human perspective," said Dr. Morgenstern, clinical director, TLC Laser Eye Centers, Washington, DC, region. "Without a great, caring optometrist taking care of a refractive surgery patient's needs on a daily, weekly, and monthly basis, you're not going to have a happy patient."

Dr. Morgenstern offered pre- and postoperative treatment regimens specifically designed to minimize the complications and maximize the success of the two procedures.

One week prior to surgery, patients are advised to add 1,000 mg of vitamin C per day to their diets. This will continue 6 to 8 weeks following the procedure.

The day prior to the surgery, Dr. Morgenstern recommended starting treatment with gatifloxacin ophthalmic solution (Zymar, Allergan), and continuing it for 1 week after surgery.

The night before and the morning of the surgery, patients are instructed to take one dose of gabapentin (Neurontin, Pfizer) to minimize pain. Patients who are taking cyclosporine eye drops (Restasis, Allergan) should discontinue using the drops the night before surgery, and resume once the bandage contact lens is removed.

PRK postop treatment

Following the PRK procedure, patients continue to take the gatifloxacin for approximately 1 week, gabapentin as needed for 4 days, vitamin C for 6 to 8 weeks, a non-steroidal anti-inflammatory agent on occasion, and cyclosporine indefinitely.

Dr. Morgenstern also adds a mild steroid, such as fluorometholone ophthalmic suspension (FML, Allergan) or loteprednol etabonate ophthalmic suspension (Alrex, Bausch + Lomb) for several weeks, and a lubricating eye drop, chilled in the refrigerator, at least q.i.d. for a few months. Dr. Morgenstern specifies preservative-free lubricating drops for the first week.

"Immediately after PRK, when the bandage contact lens is on the eye, the most important thing to watch for is infection," Dr. Morgenstern said. "The eye is in a post-operative state, and because of the contact lens, it's in the early stages of a hypoxic environment. You need to watch for infection from the operating room, infection from the environment, the patient's own lids and lashes, and so on.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Carolyn Majcher, OD, FAAO, detailed a talk she gave alongside Mary Beth Yackey, OD, at Optometry's Meeting 2025.
Shelby Brogdon, OD, details opportunities for practices to answer the patient's concerns from the chair before they hit the internet for their contact lens needs.
Christi Closson, OD, FAAO, shares her excitement for the new Acuvue Oasys MAX 1-Day multifocal for astigmatism
Karen R. Hoffman, OD, shares how customizable scleral lenses can transform vision for patients with complex corneas, achieving 20/20 outcomes and enhanced comfort.
Janna Pham, OD, shares key takeaways from a corneal tomography session she presented alongside Travis Pfeifer, OD, and Matthew McGee, OD.
Jacob Lang, OD, FAAO, details early symptom relief demonstrated in as early as day 1 during AOA's Optometry's Meeting 2025.
When Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO, began fitting scleral lenses 20 years ago, there was limited knowledge about conjunctival characteristics, scleral shape, and lens behavior.
Ioussifova details what sets Johnson & Johnson's new lens apart from the rest, which was launched at the American Optometric Association's Optometry's Meeting 2025.
Alongside Rachel Steele, OD, Rafieetary outlines what to look for in blurred disc margins and the importance of acting fast and sending patients to the ED when needed.
Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO, emphasized that every staff member should play a role in myopia management during his presentation at Optometry's Meeting 2025.
© 2025 MJH Life Sciences

All rights reserved.